China Pediatric Pharmaceuticals (CPDU) Return on Equity ROE from the first quarter 2014 to first quarter 2013 and annually, average high and low, overall ranking from Mar 31 2014 to Mar 31 2013 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
China Pediatric Pharmaceuticals, Inc.  (CPDU)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

China Pediatric Pharmaceuticals's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for China Pediatric Pharmaceuticals in the first quarter 2014?
China Pediatric Pharmaceuticals, Inc. achieved a return on average equity (ROE) of 30.39 % in its first quarter 2014 a new company high.

While the company's net income was fading, China Pediatric Pharmaceuticals was able to improve its ROE compared to the fourth quarter 2013.

Within the Healthcare Facilities industry only one company had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2013 from 0 to 257.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter
Y / Y Equity Change 38.71 % -3.38 % -62 % -68.27 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 2 -1 -10 -13 -12
Return On Equity (TTM) 30.39 % -10.18 % -126.63 % -130.54 % -93.19 %
CPDU's Total Ranking # 257 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 10 11 6 6 7
Seq. Equity Change -14.33 % 98.2 % -3.61 % -15.25 % -40.33 %
Seq. Net Income Change - - - - -

Back to CPDU Management Effectiveness >> CPDU's 5 Years Annual ROE >> Compare CPDU ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 2
Sector # 50
Overall # 257

Return On Equity Statistics
High Average Low
30.39 %
-64.32 %
-130.54 %
(Mar 31 2014)   (Jun 30 2013)





CPDU Annual Return On Equity (Dec 31 2013)
2013		 (Dec 31 2012)
2012		 (Dec 31 2010)
2011

Total Equity in Millions 11 12 24 0 0
Y / Y Equity Change -3.38 % -50.8 % - - -
Net Income in Millions -1 -9 6 0 0
Y / Y Net Income Change - - - - -
Return On Equity -6.74 % -78.77 % 25.28 % - -

Back to CPDU Management Effectiveness >> CPDU's 5 Years Annual ROE >> Compare CPDU ROE to its Competitors




More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CPDU's' Return on Equity at Yahoo Finance
CPDU's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CPDU's Competitors
Subscribers only: Roe for China Pediatric Pharmaceuticals's Suppliers
Subscribers only: Return On Equity for CPDU's Customers




Companies with similar Return On Equity at Mar 31 2014, within Healthcare Sector ROE
Eternity Healthcare Inc.  75.59 %
Sonoma Pharmaceuticals Inc   73.56 %
Bausch Health Companies Inc   61.51 %
Lightwave Logic Inc   56.48 %
Assertio Holdings inc   56.44 %
Sunwin Stevia International Inc.  53.46 %
Nanostring Technologies Inc   49.19 %
Insys Therapeutics, Inc.  46.54 %
Portola Pharmaceuticals inc   45.98 %
Lftd Partners Inc   45.65 %
Sorrento Therapeutics Inc   42.40 %
Bard C R Inc  41.47 %
Fonar Corporation  40.31 %
Bioage Labs Inc   40.28 %
Oramed Pharmaceuticals Inc  39.19 %
Gilead Sciences Inc   38.03 %
Milestone Scientific Inc   36.84 %
Idexx Laboratories Inc  35.84 %
Mettler toledo International Inc   35.44 %
Taro Pharmaceutical Industries Ltd  35.36 %
Lifevantage Corp  33.49 %
China Biologic Products Holdings Inc   33.24 %
Luna Innovations Inc  33.14 %
Veru Inc   31.23 %
Psychemedics Corporation  30.88 %
China Pediatric Pharmaceuticals, Inc.  30.39 %
Remedent Inc   29.68 %
Pfizer Inc  27.86 %
3m Company  26.23 %
Varian Medical Systems Inc   26.10 %

Date modified: 2026-09-08T15:08:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.